What are limitations of typical antipsychotics?

EPS (blocking nigrostriatal symptoms) and TD in 20-50% of patients Prolactin elevation 30% of patients remain psychotic Minimal improvement in negative symptoms Failure to improve cognitive function Limited effect on depression and suicidality Poor compliance and increased relapse Minimal improvement in overall function